Exelixis
EXEL
#1827
Rank
C$16.00 B
Marketcap
C$59.68
Share price
-1.20%
Change (1 day)
13.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: C$0.93 Billion

According to Exelixis's latest financial reports the company's current earnings are C$2.28 Billion. In 2024 the company made an earning of C$0.93 Billion, an increase over its 2023 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024C$0.93 B164.69%
2023C$0.35 B9.89%
2022C$0.32 B-20.33%
2021C$0.40 B124.82%
2020C$0.17 B-67.14%
2019C$0.54 B-11.94%
2018C$0.61 B185.09%
2017C$0.21 B-325.82%
2016-C$96.05 Million-58.12%
2015-C$0.23 Billion-37.61%
2014-C$0.37 Billion9.75%
2013-C$0.34 Billion65.96%
2012-C$0.21 Billion-291.63%
2011C$0.10 B-195.59%
2010-C$0.12 Billion-42.17%
2009-C$0.2 Billion-18.98%
2008-C$0.24 Billion-6.99%
2007-C$0.26 Billion46.3%
2006-C$0.18 Billion33.25%
2005-C$0.13 Billion-30.92%
2004-C$0.19 Billion44.29%
2003-C$0.14 Billion12.86%
2002-C$0.12 Billion22.79%
2001-C$93.89 Million60.14%
2000-C$58.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.31 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.21 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.27 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.44 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.58 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.98 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.75 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-C$44.54 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$39.72 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA